Zobrazeno 1 - 10
of 131
pro vyhledávání: '"John Teerlink"'
Autor:
Holmes D
Publikováno v:
Lancet (London, England) [Lancet] 2011 Aug 20; Vol. 378 (9792), pp. 657.
Autor:
David R. Holmes
Publikováno v:
The Lancet. 378:657
Autor:
Holmes, David
Publikováno v:
Lancet. 8/20/2011, Vol. 378 Issue 9792, p657-657. 1p.
Autor:
Antoni Bayes‐Genis, Alberto Aimo, Pardeep Jhund, Mark Richards, Rudolf A. de Boer, Henrike Arfsten, Iacopo Fabiani, Josep Lupón, Stefan D. Anker, Arantxa González, Vincenzo Castiglione, Marco Metra, Christian Mueller, Julio Núñez, Patrick Rossignol, Andrea Barison, Javed Butler, John Teerlink, Gerasimos Filippatos, Piotr Ponikowski, Giuseppe Vergaro, Faiez Zannad, Petar Seferovic, Giuseppe Rosano, Andrew J.S. Coats, Michele Emdin, James L. Januzzi
Publikováno v:
EUROPEAN JOURNAL OF HEART FAILURE
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
The approval of new heart failure (HF) therapies has slowed over the past two decades in part due to the high costs of conducting large randomized clinical trials that are needed to adequately power major clinical endpoint studies. Several biomarkers
Autor:
Wayne C. Levy, Paul Hauptman, Edward Gilbert, Peter Carson, John Teerlink, Eugene Chung, Robert Bourge, Marie-Elena Brett, John Henderson, Greg Ginn, Alan Miller
Publikováno v:
Journal of Cardiac Failure. 28:S91-S92
Autor:
Adriaan Voors, Christiane Angermann, John Teerlink, Sean Collins, Mikhail Kosiborod, Jan Biegus, Joao Pedro Ferreira, Michael Nassif, Mitchell Psotka, Jasper Tromp, Martina Bruekmann, Jon Blatchford, Afshin Salasali, Piotr Poniikowski
Publikováno v:
Heart & Lung. 55:172
Autor:
Giuseppe M C, Rosano, Larry A, Allen, Amr, Abdin, Joann, Lindenfeld, Eileen, O'Meara, Carolyn S P, Lam, Patrizio, Lancellotti, Gianluigi, Savarese, Stephen S, Gottlieb, John, Teerlink, Jan, Wintrich, Michael, Böhm
Publikováno v:
JACC. Heart failure. 9(11)
Medications with proven benefit in patients with heart failure with reduced ejection fraction are recommended, according to prospective large clinical trials, in the stable patient after careful up-titration in a strict sequential order. Although the
Autor:
Mona, Fiuzat, Naomi, Lowy, Norman, Stockbridge, Marco, Sbolli, Federica, Latta, JoAnn, Lindenfeld, Eldrin F, Lewis, William T, Abraham, John, Teerlink, Mary, Walsh, Paul, Heidenreich, Biykem, Bozkurt, Randall C, Starling, Scott, Solomon, G Michael, Felker, Javed, Butler, Clyde, Yancy, Lynne W, Stevenson, Christopher, O'Connor, Ellis, Unger, Robert, Temple, John, McMurray
Publikováno v:
JACC. Heart failure. 8(6)
Heart failure (HF) patients experience a high burden of symptoms and functional limitations, and morbidity and mortality remain high despite successful therapies. The majority of HF drugs in the United States are approved for reducing hospitalization
Autor:
Tor Biering-Sorensen, Alexander Papolos, John Teerlink, G. Michael Felker, John McMurray, Jason Legg, Fady Malik, Narimon Honarpour, Christopher Kurtz, Scott D. Solomon
Publikováno v:
Journal of the American College of Cardiology. 75:667
Autor:
Marco Metra, Douwe Postmus, Beth Davison, Hans L. Hillege, Daniel Bloomfield, Piotr Ponikowski, John Teerlink, Michael Givertz, Gad Cotter, John Cleland, Howard Dittrich, Biniyam G. Demissei, Adriaan A. Voors, Licette C. Y. Liu, Christopher M. O'Connor
Publikováno v:
Journal of the American College of Cardiology, 67(13), 1440-1440. ELSEVIER SCIENCE INC
There is substantial variation in the etiology, clinical presentation and pathophysiology of patients hospitalized for acute heart failure (AHF) that may influence their natural history and response to therapy. We performed a post-hoc analysis of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb3ff7d79e3299f5109012dbba968d4
https://research.rug.nl/en/publications/7fd6cbe2-5cbc-430f-a03e-0552090f2be7
https://research.rug.nl/en/publications/7fd6cbe2-5cbc-430f-a03e-0552090f2be7